25th Lorne Cancer Conference 2013
Thursday, 14th February
Friday, 15th February
Saturday, 16th February
Abstracts this author is presenting:
Receptor Tyrosine Kinases differ in their ability to confer resistance to Vemurafenib (PLX4032) treatment in BRAFV600E melanoma.
Poster Session 1